企業プロフィール
Ironwood Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- IRWD
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
4.36 USD (+1.16%)
終値
最終更新: 2026年8月17日
540M USD
時価総額
株価変動の要因
As of Aug 17, 2026, IRWD closed up 1.16% at $4.36. No new same-company headline was identified in the current news window.
企業概要
事業概要
Ironwood Pharmaceuticals is a gastrointestinal-focused company anchored by Linzess and a pipeline aimed at digestive health. Its story is centered on GI commercialization and pipeline extension.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Ironwood sits in specialty biopharma.
ビジネスモデルの特徴
The business combines commercial GI revenue with pipeline optionality, so investors track prescription trends, partnership economics, and product durability.
バイオ業界での位置付け
Ironwood is a commercial specialty-pharma name whose valuation is tied to a limited number of digestive-health assets and their lifecycle.
今後のカタリスト
- Ironwood's catalysts are Linzess execution, GI commercial stability, and any pipeline or partnership update that clarifies the next growth vector. The company still needs the core franchise to stay durable.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。